Westside Investment Management’s Vertex Pharmaceuticals VRTX Stock Holding History

Westside Investment Management’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$88.9K	Hold	179	–	–	0.01%	455
2026 Q1	$78.6K	Hold	179	–	–	0.01%	459
2025 Q4	$80.9K	Buy	179 +3	+2%	+$1.29K	0.01%	432
2025 Q3	$71.1K	Buy	176 +73	+71%	+$30.5K	0.01%	461
2025 Q2	$46.6K	Buy	103 +73	+243%	+$33.6K	0.01%	471
2025 Q1	$14.5K	Buy	30 +17	+131%	+$7.92K	﹤0.01%	625
2024 Q4	$5.24K	Hold	13	–	–	﹤0.01%	768
2024 Q3	$6.58K	Hold	13	–	–	﹤0.01%	743
2024 Q2	$6.09K	Buy	+13	New	+$5.64K	﹤0.01%	730
2020 Q3	–	Sell	-10	Closed	-$2	–	701
2020 Q2	$2	Buy	+10	New	+$2.71K	﹤0.01%	604

Other funds holding VRTX

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Westside Investment Management's VRTX Position: Q2 2026 in Review

Westside Investment Management held its Vertex Pharmaceuticals (VRTX) position steady in Q2 2026 at 179 shares worth $88.9K. The position accounts for 0.01% of the portfolio, ranked #455.

Westside Investment Management first reported a position in VRTX in Q2 2020 and has held it in 10 quarters since. 1,761 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

Westside Investment Management held 179 shares of Vertex Pharmaceuticals worth $88.9K as of Q2 2026.
Westside Investment Management left its Vertex Pharmaceuticals share count unchanged in Q2 2026.
Vertex Pharmaceuticals made up 0.01% of Westside Investment Management's portfolio in Q2 2026, its #455 holding.
Westside Investment Management first reported a position in Vertex Pharmaceuticals in Q2 2020 and has held it in 10 quarters since.
1,761 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Westside Investment Management's 13F filing for Q2 2026, filed 27 Jul 2026.